Response to: Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogeneic Hematopoietic Cell Transplantation

Intern Med. 2023 Mar 1;62(5):815. doi: 10.2169/internalmedicine.0482-22. Epub 2022 Jul 22.

Authors

Ryo Yanagiya¹, Masahiro Wanezaki², Tomomi Toubai¹, Masafumi Watanabe², Kenichi Ishizawa¹

Affiliations

¹ Department of Neurology, Hematology, Diabetology, Endocrinology, and Metabolism (3rd Department of Internal Medicine), Faculty of Medicine, Yamagata University, Japan.
² 1st Department of Internal Medicine, Faculty of Medicine, Yamagata University, Japan.

No abstract available

Keywords: allo-HCT; heart failure; ivabradine.

Publication types

Letter
Comment

MeSH terms

Heart Failure*
Heart Rate
Hematopoietic Stem Cell Transplantation*
Humans
Ivabradine
Tachycardia, Sinus

Substances

Ivabradine